Filing Details

Accession Number:
0001209191-10-034134
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-14 13:00:00
Reporting Period:
2010-06-10
Filing Date:
2010-06-14
Accepted Time:
2010-06-14 20:52:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021412 W Jack Schuler 10165 Mckellar Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-10 46,305 $10.70 587,906 No 4 P Indirect by Schuler Family Foundation
Common Stock Acquisiton 2010-06-11 58,220 $10.77 646,126 No 4 P Indirect by Schuler Family Foundation
Common Stock Acquisiton 2010-06-14 5,000 $11.25 651,126 No 4 P Indirect by Schuler Family Foundation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Schuler Family Foundation
No 4 P Indirect by Schuler Family Foundation
No 4 P Indirect by Schuler Family Foundation
Footnotes
  1. The weighted average purchase price for these transactions was $10.6983 per share, with a range of $10.665 to $10.745 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  2. The shares reported herein were acquired and purchased by the Reporting Person's family foundation. The Reporting Person disclsims all beneficial ownership of these shares. The Reporting Person's beneficial ownership consists of 2,667,288 shares, which excludes 65,000 shares held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the 65,000 shares owned by his spouse, except to the etent of his pecuniary interest, if any.
  3. The weighted average purchase price for these transactions was $10.7703 per share, with a range of $10.605 to $10.85 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  4. The weighted average purchase price for these transactions was $11.2527 per share, with a range of $11.235 to $11.27 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.